The initial public offering of Gaudium IVF and Women Health has garnered robust investor interest, achieving full subscription by the second day of bidding and reflecting rising confidence in niche healthcare businesses tapping the capital markets. According to exchange data available during the subscription window, the issue was subscribed 1.67 times by late morning on the second day, with retail and non institutional investors driving the demand.

The offering, valued at approximately ₹165 crore, received bids for about 2.44 crore shares against roughly 1.46 crore shares available. Retail investors accounted for the bulk of participation, subscribing their quota 2.41 times, while the non institutional category saw subscriptions of around 2.18 times. Institutional participation details were comparatively muted at this stage, indicating that the momentum was primarily retail led.

On the first day, the issue had already secured nearly 88 percent subscription, setting the stage for oversubscription as the bidding progressed. Prior to opening for public subscription, the company had raised ₹49.5 crore from anchor investors, providing early validation and reducing execution risk. The price band for the IPO was set at ₹75–79 per share, implying an estimated valuation of around ₹575 crore at the upper end.

Gaudium IVF is positioning itself as a specialized fertility care provider at a time when assisted reproductive services are witnessing rapid growth in India due to rising infertility awareness, delayed parenthood trends, urban lifestyle factors, and improving medical accessibility. The company plans to deploy the proceeds primarily toward establishing 19 new IVF centres across the country, alongside debt repayment and general corporate purposes. Expansion-led capital deployment indicates a strategy focused on scaling physical infrastructure and market presence rather than purely strengthening the balance sheet.

If executed successfully, the planned expansion could significantly increase the company’s geographic footprint in a sector that remains highly fragmented and concentrated in urban clusters. India’s fertility services market has seen increasing institutional interest over the past decade, with private equity investments and consolidation efforts highlighting its long-term growth potential.

Market expectations around the listing appear cautious but positive. Informal grey market activity suggests a premium of roughly ₹7–8 per share, translating into a potential listing gain in the high single-digit range. Such moderate premiums typically indicate stable demand without signs of speculative overheating. However, grey market indicators are unofficial and can change rapidly depending on broader market sentiment and subscription outcomes in the final hours of bidding.